Target intelligence / Profile preview

Occlusion of endoleak cavity

Overview

Occlusion of endoleak cavity refers to a vascular intervention procedure used to treat endoleaks, which are complications that occur after endovascular aneurysm repair (EVAR) for aortic aneurysms. An endoleak is defined as persistent blood flow outside a stent graft but within the aneurysm sac, risking continued pressurization and possible rupture of the aneurysm sac. Occlusion of the endoleak cavity is typically achieved via embolization, in which materials (such as glue, coils, or liquid embolics) are introduced into the endoleak cavity through percutaneous or endovascular approaches to block abnormal blood flow and seal the space. This is a clinical or procedural term, not a molecular or pharmacological target.

Other names: Embolization of endoleak cavityAneurysm sac embolizationEndoleak cavity occlusion

Beyond the preview

Go deeper on Occlusion of endoleak cavity.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Occlusion of endoleak cavity.

Explore the full profile